Wolff Wiese Magana’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $149K | Buy |
1,706
+48
| +3% | +$4.19K | 0.09% | 122 |
|
|
2025
Q1 | $113K | Buy |
1,658
+24
| +1% | +$1.64K | 0.08% | 125 |
|
|
2024
Q4 | $127K | Sell |
1,634
-13
| -0.8% | -$1.01K | 0.08% | 129 |
|
|
2024
Q3 | $110K | Buy |
1,647
+1
| +0.1% | +$67 | 0.08% | 133 |
|
|
2024
Q2 | $187K | Hold |
1,646
| – | – | 0.15% | 90 |
|
|
2024
Q1 | $228K | Hold |
1,646
| – | – | 0.2% | 81 |
|
|
2023
Q4 | $204K | Buy |
1,646
+16
| +1% | +$1.99K | 0.19% | 81 |
|
|
2023
Q3 | $152K | Sell |
1,630
-4
| -0.2% | -$373 | 0.12% | 109 |
|
|
2023
Q2 | $210K | Hold |
1,634
| – | – | 0.16% | 89 |
|
|
2023
Q1 | $190K | Buy |
1,634
+30
| +2% | +$3.49K | 0.15% | 96 |
|
|
2022
Q4 | $182K | Sell |
1,604
-112
| -7% | -$12.7K | 0.16% | 98 |
|
|
2022
Q3 | $138K | Hold |
1,716
| – | – | 0.11% | 140 |
|
|
2022
Q2 | $128K | Buy |
1,716
+4
| +0.2% | +$298 | 0.09% | 150 |
|
|
2022
Q1 | $219K | Buy |
1,712
+36
| +2% | +$4.61K | 0.15% | 117 |
|
|
2021
Q4 | $225K | Sell |
1,676
-20
| -1% | -$2.69K | 0.15% | 122 |
|
|
2021
Q3 | $232K | Sell |
1,696
-24
| -1% | -$3.28K | 0.16% | 114 |
|
|
2021
Q2 | $184K | Buy |
1,720
+120
| +8% | +$12.8K | 0.13% | 130 |
|
|
2021
Q1 | $144K | Sell |
1,600
-1,200
| -43% | -$108K | 0.11% | 150 |
|
|
2020
Q4 | $259K | Buy |
+2,800
| New | +$259K | 0.22% | 96 |
|